Search PubMedSearch

PubMed · 3035951

Synovial sarcoma.

Abstract

The contributions of Dr. Arthur Purdy Stout to surgical pathology and his observations pertaining to soft tissue tumors (and, more specifically, to synovial sarcoma) are briefly reviewed. In addition, a report on 185 patients treated at the Mayo Clinic for synovial sarcoma is reviewed. In that study, histologic subclassification stratified the tumors as follows: 33% with a predominant biphasic pattern, 31% with a monophasic pattern, and 36% with a mixed pattern. For all 185 patients, the 5-year survival rate was 38% and the 10-year rate was 23%. For patients treated since 1960, the survival rates were 55% at 5 years and 38% at 10 years. Female patients, young patients, and patients with tumors less than 5 cm in diameter had significantly higher survival rates than did their counterparts. Although histologic subtyping did not reveal significant differences in patient survival, patients with glandular differentiation of the epithelial elements seemed to do better.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

E H Soule. 1986. Synovial sarcoma.. https://pubmed.ncbi.nlm.nih.gov/3035951/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

P210 Bcr-Abl interacts with the interleukin 3 receptor beta(c) subunit and constitutively induces its tyrosine phosphorylation.

Chronic myelogenous leukemia is a neoplasm of pluripotent hematopoietic cells. The P210 Bcr-Abl oncoprotein is a deregulated cytoplasmic tyrosine kinase that has been shown to cause chronic myelogenous leukemia-like neoplasms in mice. Cytokines such as interleukin 3 and granulocyte/macrophage-colony-stimulating factor regulate the growth and differentiation of hematopoietic precursors. These cytokines activate two distinct signals to the nucleus. One signal is through the Ras pathway, and the second involves activation of Jak2. We demonstrated that Bcr-Abl co-immunoprecipitates with, and constitutively phosphorylates, the common beta(c) subunit of the interleukin 3 and granulocyte/macrophage-colony-stimulating factor receptors. Our data show that formation of this complex leads to the constitutive tyrosine phosphorylation of Jak2. It has been demonstrated that Bcr-Abl interacts with Grb2 and Shc, which in turn activates the Ras pathway. Our new findings raise the possibility that Bcr-Abl activates signaling through both pathways in a factor-independent fashion.

Cell Transformation, Neoplastic

Enhanced secretion and activation of matrilysin during malignant conversion of human colorectal epithelium and its relationship with invasive potential of colon cancer cells.

BACKGROUND: Matrilysin is a member of the matrix metalloproteinase gene family which is believed to play an important role in tumor progression. Matrilysin mRNA has been reported to be overexpressed in colorectal cancer. The aim of this study was to evaluate the enzyme activity of this protein during colorectal cancer. The aim of this study was to evaluate the enzyme activity of this protein during colorectal carcinogenesis and its relationship with the invasiveness of colorectal cancer cells. METHODS: We have examined the levels of secreted matrilysin in various epithelial disorders of the colon using casein zymography. We have also examined the effect of matrilysin on the in vitro invasiveness of colorectal cancer cells using a modified Boyden Chamber method. RESULTS: The enzyme activities of matrilysin were detected in cancer tissue and adenoma tissue, whereas they were hardly detectable in hyperplastic polyps, mildly inflamed regions of ulcerative colitis, and normal colon tissue. Enhanced secretion and enhanced activation of matrilysin were observed in cancer. An in vitro invasion assay revealed that the levels of secreted matrilysin-transfectants correlated positively with invasiveness. CONCLUSIONS: Our data suggest that the secretion and activation of matrilysin may be up-regulated during malignant conversion of colorectal epithelium. Matrilysin appears to contribute to in vitro invasiveness of colon cancer cells. Inhibitors of the enzyme may be of value in preventing colorectal cancer progression.

Cell Transformation, Neoplastic

Telomeres and disease.

Explore the source record for details and available documents.

Cell Transformation, Neoplastic